Why the study?
Does electroanatomic mapping (EAM) guided biventricular device implantation reduce radiation exposure and improve outcomes in patients with heart failure?
Does electroanatomic mapping (EAM) guided biventricular device implantation reduce radiation exposure and improve outcomes in patients with heart failure?
While EAM-guided biventricular device implantation may reduce radiation exposure and help identify optimal LV pacing sites, larger randomized trials and cost-effectiveness analyses are needed before routine use can be recommended.
Biventricular devices play an important adjunctive role in the treatment of heart failure. However, biventricular device implantation is associated with significant radiation exposure and a high proportion of non-response to cardiac resynchronization therapy (CRT). The use of electroanatomic mapping (EAM) during biventricular device implantation may help overcome these issues. This article will review the literature on the role of EAM in biventricular device implantation.
No takes yet. Share an insight, caveat, or question.
Chan et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: